Cite Filings / AMLX / 0001193125-25-004002

Feed Companies Filings Check

Sign in

424B5

Prospectus

Amylyx Pharmaceuticals, Inc. Filed 2025-01-10 Acc 0001193125-25-004002

Documents 1

424B5 Prospectus , d922830d424b5.htm

Around this filing

2025-01-14 SCHEDULE 13G Statement of Beneficial Ownership
2025-01-10 8-K Material agreement
2025-01-10 424B5 Prospectus
2025-01-10 424B5 Prospectus
2025-01-08 4 Co-Chief Executive Officer sold 7,471 shares at $4.04 ($30,202)
2025-01-08 4 Co-Chief Executive Officer sold 7,471 shares at $4.05 ($30,232)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d922830d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…